CN100528207C - Medicine for treating pulmonary tuberculosis and its preparing process - Google Patents
Medicine for treating pulmonary tuberculosis and its preparing process Download PDFInfo
- Publication number
- CN100528207C CN100528207C CNB2004100411448A CN200410041144A CN100528207C CN 100528207 C CN100528207 C CN 100528207C CN B2004100411448 A CNB2004100411448 A CN B2004100411448A CN 200410041144 A CN200410041144 A CN 200410041144A CN 100528207 C CN100528207 C CN 100528207C
- Authority
- CN
- China
- Prior art keywords
- medicine
- bulbus allii
- container
- treatment
- sal
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
The invention discloses a medicament for treating pulmonary tuberculosis characterized by that, the medicament comprises toasted garlic as the raw material, as well as raw material table salt and mint. The invention also discloses the method for preparing and use of the phthisis-treating medicament.
Description
Technical field
The present invention relates to a kind of is the medicine of raw material with the Chinese herbal medicine, the phthisical medicine of particularly a kind of treatment.
Background technology
Tuberculosis is a kind of more common chronic infectious disease that is caused by mycobacterium tuberculosis infection.Tuberculosis all can take place in the various tissues of human body and each organ, but the most common with lungs, the tuberculosis that betides pulmonary then is called pulmonary tuberculosis.According to statistics, China has 500,000,000 people to infect tuberculosis approximately, and pulmonary tuberculosis patient more than 600 ten thousand is arranged, and has every year more than 30 ten thousand people to die from tuberculosis approximately.Though pulmonary tuberculosis can thoroughly be cured,, can produce fastbacteria and form refractory pulmonary tuberculosis if control inadequate or the positive partner treatment of patient.
Being used for the treatment of phthisical Western medicine in the prior art mainly contains following several: isoniazid, its main side effects are easy excitement, insomnia, refreshing directly scorching, the even liver function injury that has of tip; Rifampicin, its main side effects are liver function injury, thrombocytopenia, the easy teratogenesis tire of pregnant early stage women; Pyrazinamide, its main side effects are gastrointestinal reaction, liver function injury, arthralgia; Ethambutol, its main side effects is a visual deterioration.More than several Western medicine generally all be used in combination during pulmonary tuberculosis in treatment, though certain therapeutic effect is also arranged, its toxic and side effects can bring new disease with painful to the patient.So the phthisical medicine of the treatment that develop good effect, has no side effect is very urgent, this also is a major issue that promotes the well-being of mankind.
Summary of the invention
Technical problem to be solved by this invention is at the deficiencies in the prior art, proposes the phthisical medicine of a kind of treatment evident in efficacy, that have no side effect.
Technical problem to be solved by this invention is to realize by following technical scheme.The present invention is the phthisical medicine of a kind of treatment, is characterized in that the raw material of making active ingredient consists of,
(1) Bulbus Allii; (2) Sal and Herba Menthae.
Technical problem to be solved by this invention can also further realize by following technical scheme.The phthisical medicine of above-described a kind of treatment is characterized in, the weight percent content of raw material is,
(1) Bulbus Allii 9099%; (2) Sal or Herba Menthae 1-10%;
Perhaps,
(1) Bulbus Allii 80-98%; (2) Sal 1-10%, Herba Menthae 1-10%.
A kind of preparation method of medicine of the present invention is, gets Bulbus Allii, and peeling perhaps adds Sal and new fresh mint leaf, places container to mash, and stirs to be placed in the volatilizable medicated bag or container that goes out abnormal smells from the patient, promptly.A kind of using method of this medicine is, prepared medicine is placed hermetic container, forces air-supplied or oxygen in container, and the gas that bound drug is volatilized sucks the human lung by pipeline.
Be the clinical trial that the inventor did below.
1, clinical trial medicine.
Side one: Bulbus Allii 50 grams mash;
Side two: Bulbus Allii 50 grams, Sal 3 grams mash, and stir;
Side three: Bulbus Allii 50 grams, new fresh mint leaf 3 grams mash, and stir;
Fang Si: Bulbus Allii 50 grams, Sal 3 grams, new fresh mint leaf 3 grams mash, and stir;
Respectively said medicine is placed the respiratory therapy instrument, allow the patient suck pulmonary, every day 2 times, inhaled 2-6 hour at every turn.Use 3 courses of treatment, 3 months each courses of treatment.
2, clinical patients correlation circumstance.To treat component is 4 groups, every group 100 people, and I type patient 30 people wherein, II type patient 40 people, 30 of IV type patients reach the course of treatment side of giving respectively as stated above and one to Fang Si give medicine.
3, clinical test results.
Phthisical comprehensive therapeutic effect standard is as follows:
Clinical cure.Pulmonary lesion does not have activeness, and the cavity is closed, and expectorant bacterium continuously negative (looking into expectorant at least in every month 1 time) all reaches more than 6 months.Still exist as the cavity, then must the expectorant bacterium negative continuously more than 1 year.
Significantly effectively.The expectorant bacterium is continuously cloudy to be changeed, and pathological changes obviously absorbs or absorbs, and cavity closure or dwindle all reaches person more than 3 months.
Effectively.Sputum conversion, pathological changes obviously absorb, absorb or do not have a change; The cavity is closed, dwindles or does not have change, all reaches more than 1 month.The expectorant bacterium is cloudy continuously to be changeed, and pathological changes absorbs, and the cavity dwindles, and all reaches more than 1 month.
Invalid.Expectorant bacterium and X line all do not have the changer.
The clinical test results of side one sees the following form:
The clinical test results of side two sees the following form:
The clinical test results of side three sees the following form:
The clinical test results of Fang Si sees the following form:
Compared with prior art, pharmaceutical formulation of the present invention is simple, and cost is low, and is evident in efficacy.Prove that through clinical trial its average total effective rate can reach more than 98%, the treatment drug tolerance pulmonary tuberculosis is had special effect, and without any side effects to human body.Preparation of the present invention and using method are very simple, and medicine directly acts on the human lung, and instant effect prevents the effect of secondary morbidity in addition to the people that the tuberculosis medical history was arranged.Medicine of the present invention can be used for various types of pulmonary tuberculosis treatment of diseases, also can be used for the treatment of other pneumonopathy and upper respiratory disease.
The specific embodiment
Embodiment 1.The phthisical medicine of a kind of treatment, it is to be the medicine that raw material is made with the Bulbus Allii.During use, get Bulbus Allii, peeling, place container to mash, stirring is placed in the volatilizable medicated bag or container that goes out abnormal smells from the patient, is placed in the hermetic container again, force air-supplied or oxygen in container, the gas that bound drug is volatilized sucks the human lung by pipeline.
Embodiment 2.The phthisical medicine of a kind of treatment, it is the medicine made from Bulbus Allii and Sal, and wherein Bulbus Allii content is 99%, and salt content is 1%.During use, get Bulbus Allii, peeling, add Sal, place container to mash, stirring is placed in the volatilizable medicated bag or container that goes out abnormal smells from the patient, is placed in the hermetic container again, force air-supplied or oxygen in container, the gas that bound drug is volatilized sucks the human lung by pipeline.
Embodiment 3.The phthisical medicine of a kind of treatment, it is the medicine made from Bulbus Allii and Sal, and wherein Bulbus Allii content is 90%, and salt content is 10%.During use, get Bulbus Allii, peeling, add Sal, place container to mash, stirring is placed in the volatilizable medicated bag or container that goes out abnormal smells from the patient, is placed in the hermetic container again, force air-supplied or oxygen in container, the gas that bound drug is volatilized sucks the human lung by pipeline.
Embodiment 4.The phthisical medicine of a kind of treatment, it is the medicine made from Bulbus Allii and Sal, and wherein Bulbus Allii content is 95%, and salt content is 5%.During use, get Bulbus Allii, peeling, add Sal, place container to mash, stirring is placed in the volatilizable medicated bag or container that goes out abnormal smells from the patient, is placed in the hermetic container again, force air-supplied or oxygen in container, the gas that bound drug is volatilized sucks the human lung by pipeline.
Embodiment 5.The phthisical medicine of a kind of treatment, it is the medicine made from Bulbus Allii and Herba Menthae, and wherein Bulbus Allii content is 90%, and Herba Menthae content is 10%.During use, get Bulbus Allii, peeling, add Herba Menthae, place container to mash, stirring is placed in the volatilizable medicated bag or container that goes out abnormal smells from the patient, is placed in the hermetic container again, force air-supplied or oxygen in container, the gas that bound drug is volatilized sucks the human lung by pipeline.
Embodiment 6.The phthisical medicine of a kind of treatment, it is the medicine made from Bulbus Allii and Herba Menthae, and wherein Bulbus Allii content is 95%, and Herba Menthae content is 5%.During use, get Bulbus Allii, peeling, add Herba Menthae, place container to mash, stirring is placed in the volatilizable medicated bag or container that goes out abnormal smells from the patient, is placed in the hermetic container again, force air-supplied or oxygen in container, the gas that bound drug is volatilized sucks the human lung by pipeline.
Embodiment 7.The phthisical medicine of a kind of treatment, it is the medicine made from Bulbus Allii and Herba Menthae, and wherein Bulbus Allii content is 99%, and Herba Menthae content is 1%.During use, get Bulbus Allii, peeling, add Herba Menthae, place container to mash, stirring is placed in the volatilizable medicated bag or container that goes out abnormal smells from the patient, is placed in the hermetic container again, force air-supplied or oxygen in container, the gas that bound drug is volatilized sucks the human lung by pipeline.
Embodiment 8.The phthisical medicine of a kind of treatment, it is the medicine made from Bulbus Allii, Sal and Herba Menthae, and wherein Bulbus Allii content is 98%, and salt content is 1%, and Herba Menthae content is 1%.During use, get Bulbus Allii, peeling, add Sal and new fresh mint leaf, place container to mash, stirring is placed in the volatilizable medicated bag or container that goes out abnormal smells from the patient, is placed in the hermetic container again, force air-supplied or oxygen in container, the gas that bound drug is volatilized sucks the human lung by pipeline.
Embodiment 9.The phthisical medicine of a kind of treatment, it is the medicine made from Bulbus Allii, Sal and Herba Menthae, and wherein Bulbus Allii content is 80%, and salt content is 10%, and Herba Menthae content is 10%.During use, get Bulbus Allii, peeling, add Sal and new fresh mint leaf, place container to mash, stirring is placed in the volatilizable medicated bag or container that goes out abnormal smells from the patient, is placed in the hermetic container again, force air-supplied or oxygen in container, the gas that bound drug is volatilized sucks the human lung by pipeline.
Embodiment 10.The phthisical medicine of a kind of treatment, it is the medicine made from Bulbus Allii, Sal and Herba Menthae, and wherein Bulbus Allii content is 90%, and salt content is 5%, and Herba Menthae content is 5%.During use, get Bulbus Allii, peeling, add Sal and new fresh mint leaf, place container to mash, stirring is placed in the volatilizable medicated bag or container that goes out abnormal smells from the patient, is placed in the hermetic container again, force air-supplied or oxygen in container, the gas that bound drug is volatilized sucks the human lung by pipeline.
Claims (1)
1, the phthisical medicine of a kind of treatment is characterized in that, raw material composition and the weight percent content thereof of making active ingredient are:
(1) Bulbus Allii 90-99%; (2) Sal or Herba Menthae 1-10%;
Perhaps,
(1) Bulbus Allii 80-98%; (2) Sal 1-10%, Herba Menthae 1-10%.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2004100411448A CN100528207C (en) | 2004-06-29 | 2004-06-29 | Medicine for treating pulmonary tuberculosis and its preparing process |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2004100411448A CN100528207C (en) | 2004-06-29 | 2004-06-29 | Medicine for treating pulmonary tuberculosis and its preparing process |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1593590A CN1593590A (en) | 2005-03-16 |
| CN100528207C true CN100528207C (en) | 2009-08-19 |
Family
ID=34664928
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB2004100411448A Expired - Fee Related CN100528207C (en) | 2004-06-29 | 2004-06-29 | Medicine for treating pulmonary tuberculosis and its preparing process |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN100528207C (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1814176B (en) * | 2005-12-05 | 2011-06-15 | 杨雄志 | Chinese medicinal composition for treating tuberculosis and its preparation method |
| CN105687651A (en) * | 2016-02-18 | 2016-06-22 | 加木里哈·努尔太 | Externally used drug for pulmonary tuberculosis |
-
2004
- 2004-06-29 CN CNB2004100411448A patent/CN100528207C/en not_active Expired - Fee Related
Non-Patent Citations (4)
| Title |
|---|
| 不同药物雾化引痰查结核分枝杆菌结果分析. 张爱琴等.中国防痨杂志，第21卷第4期. 1999 |
| 不同药物雾化引痰查结核分枝杆菌结果分析. 张爱琴等.中国防痨杂志，第21卷第4期. 1999 * |
| 大蒜吸入治疗肺结核10例. 程润泉.浙江中医杂志，第18卷第12期. 1983 |
| 大蒜吸入治疗肺结核10例. 程润泉.浙江中医杂志，第18卷第12期. 1983 * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1593590A (en) | 2005-03-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103316219A (en) | Traditional Chinese medicinal preparation for treating phthisis and preparation method thereof | |
| CN103611075A (en) | Bezoar refreshing preparation and preparation method thereof | |
| CN101327313A (en) | Oral medication for treating epigastric pain | |
| CN103356824B (en) | Traditional Chinese medicine based narcotic drug used for tooth extraction operation and preparation method thereof | |
| CN103182064A (en) | Medicine for treating cough due to wind-cold evil and preparation method thereof | |
| CN100528207C (en) | Medicine for treating pulmonary tuberculosis and its preparing process | |
| CN104306793B (en) | A kind of Chinese medicine preparation for treating lobar pneumonia | |
| CN104888181A (en) | Moxa leaf moxa preparation and preparation thereof | |
| CN104096209A (en) | Preparation method of traditional Chinese medicine composition for dispelling cold and relieving cough and application thereof | |
| CN104998080B (en) | A kind of Chinese medicine composition for being used to treat cough variant asthma | |
| CN103721095B (en) | Be used for preventing grippal Chinese medicine preparation | |
| CN1410105A (en) | Zibei Cough stopping granules and its preparation method | |
| CN104906345A (en) | Traditional Chinese medicine composition used for treating chronic obstructive pulmonary disease in stable phase | |
| CN117298184B (en) | Composition for treating constipation and halitosis, and preparation method and application thereof | |
| CN101979015B (en) | Chinese medicinal preparation for treating respiratory diseases of chronic tracheitis, emphysema and pulmonary heart disease | |
| CN103041172B (en) | Traditional Chinese medicine composition for curing chronic nasosinusitis and preparation method thereof | |
| CN1061891C (en) | External-use ointment for chronic bronchitis and pulmonary emphysema | |
| CN1055239C (en) | Plaster for curing cough and asthma and its producing method | |
| CN105031556A (en) | Chinese herb preparation for treating cough variant asthma | |
| CN105396071A (en) | Traditional Chinese medicine formula for treating children pneumonia | |
| CN112190620A (en) | Traditional Chinese medicine composition for treating cough and chest distress and preparation and application thereof | |
| CN105055886A (en) | Traditional Chinese medicine composite for treating both-qi-and-yin-deficiency type tuberculosis | |
| CN1092976C (en) | Application of endive in preparing medicine for treating tuberculosis | |
| CN118236355A (en) | Hydrogel throat plaster for resolving phlegm and detoxifying, and preparation method and application thereof | |
| CN102145033B (en) | Traditional Chinese medicinal preparation for treating phthisis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| ASS | Succession or assignment of patent right |
Owner name: JIANGSU SHANSHEN MEDICAL DEVICES CO., LTD. Free format text: FORMER OWNER: CAI JIANHUA Effective date: 20150319 |
|
| C41 | Transfer of patent application or patent right or utility model | ||
| COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 222001 LIANYUNGANG, JIANGSU PROVINCE TO: 222000 LIANYUNGANG, JIANGSU PROVINCE |
|
| TR01 | Transfer of patent right |
Effective date of registration: 20150319 Address after: 222000 Jiangsu economic and Technological Development Zone, Lianyungang economic and Technological Development Zone, song hop hi tech Zone, Zhenhua Road, No. 15 incubator building, third floor Patentee after: The China Medical Instrument Limited company Address before: 222001, room 602, building 3, secluded garden, rose District, Lianyungang, Jiangsu, Sinpo Patentee before: Cai Jianhua |
|
| ASS | Succession or assignment of patent right |
Owner name: LIANYUNGANG XIA AN TRADING CO., LTD. Free format text: FORMER OWNER: JIANGSU SHANSHEN MEDICAL DEVICES CO., LTD. Effective date: 20150428 |
|
| C41 | Transfer of patent application or patent right or utility model | ||
| TR01 | Transfer of patent right |
Effective date of registration: 20150428 Address after: On the east side of State Road 310 North Road, Jiangsu city in Lianyungang province 222000 Dapu of Lianyungang economic and Technological Development Zone Patentee after: Lianyungang Xia an Trading Co., Ltd. Address before: 222000 Jiangsu economic and Technological Development Zone, Lianyungang economic and Technological Development Zone, song hop hi tech Zone, Zhenhua Road, No. 15 incubator building, third floor Patentee before: The China Medical Instrument Limited company |
|
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20090819 Termination date: 20150629 |
|
| EXPY | Termination of patent right or utility model |